Literature DB >> 2670032

The linear-quadratic formula and progress in fractionated radiotherapy.

J F Fowler1.   

Abstract

Mesh：

Year:  1989        PMID： 2670032     DOI： 10.1259/0007-1285-62-740-679

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  406 in total

Review 1.  The impact on oncology of the interaction of radiation therapy and radiobiology.

Authors:  Vicente Pedraza Muriel
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas.

Authors:  E C Halperin
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

3.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

Review 4.  Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.

Authors:  Nitin Ohri; Adam P Dicker; Edouard J Trabulsi; Timothy N Showalter
Journal:  Eur J Cancer       Date:  2011-09-22       Impact factor: 9.162

5.  Spanish radiobiological pattern of care in lung cancer: a GOECP/SEOR study.

Authors:  J A González; M Chust; R Delgado; A Gómez; N Rodríguez; M J Ruiz; F Casas
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

6.  Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.

Authors:  Hanan Amro; Scott J Wilderman; Yuni K Dewaraja; Peter L Roberson
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

7.  Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.

Authors:  David I Rosenthal; Abdallah S R Mohamed; Adam S Garden; William H Morrison; Adel K El-Naggar; Mona Kamal; Randal S Weber; Clifton D Fuller; Lester J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-07-10       Impact factor: 7.038

8.  Biologically effective dose and definitive radiation treatment for localized prostate cancer: treatment gaps do affect the risk of biochemical failure.

Authors:  P Sanpaolo; V Barbieri; D Genovesi
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

9.  5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.

Authors:  Matthew M Poppe; Zeinab A Yehia; Christopher Baker; Sharad Goyal; Deborah Toppmeyer; Laurie Kirstein; Chunxia Chen; D F Moore; Bruce G Haffty; Atif J Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-11       Impact factor: 7.038

10.  A Retrospective Six Years Analysis of Survival and Late Morbidity of Post-operative Gynaecological Malignancy Treated with External Radiotherapy Followed by Brachytherapy in Medical College & Hospitals, Kolkata.

Authors:  Sourav Sau; Suparna Ghosh; Shila Mitra; Amitava Manna; Bidyut Mondal; Koushik Ghosh
Journal:  J Obstet Gynaecol India       Date:  2013-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.